AGIO Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Agios Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 34.16 USD 3.26% Market Closed

Market Cap: $2B

	Agios Pharmaceuticals Inc NASDAQ:AGIO	US
C	Canadian Tire Corporation Ltd XMUN:YAAA	CA
	Spruce Biosciences Inc NASDAQ:SPRB	US
	Covestro AG F:1CO1	DE
M	Motorola Solutions Inc XHAM:MTLA	US
G	Gold Road Resources Ltd XBER:E6Q	AU
D	Discover Financial Services LSE:0IBC	US

Profitability Summary

Agios Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

90%

Strong 3Y Average Gross Margin

89%

Gross Margin is Increasing

90% > 90%

Negative Operating Margin

-720%

Negative 3Y Average Operating Margin

-777%

Operating Margin is Increasing

-1.990% > -720%

Negative Net Margin

-640%

Negative 3Y Average Net Margin

-54%

Net Margin is Increasing

-1.146% > -640%

Negative Free Cash Flow Margin

-582%

Negative 3Y Average Free Cash Flow Margin

-1.016%

Free Cash Flow Margin is Increasing

-1.627% > -582%

Negative ROE

-33%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-56%

ROIC is Increasing

-94% > -88%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.